Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deutsche Bank maintains long-term positive view on UK banks

(Sharecast News) - Deutsche Bank said on Monday that its potential long-term positive view on banks remains after the sector took a hit on Friday as the Institute for Public Policy Research suggested a potential windfall tax. "We expect the threat of taxes will continue to weigh on UK bank shares into the Autumn budget," said DB.

"Typically the news is worse than the reality and shares tend to recover quickly as policies are clarified and our long term positive view on UK banks remains."

It said the suggestion of an 'excess reserve' levy on Friday could have up to 20% earnings impact, which is a substantial overhang. This is the harshest of scenarios but this type of levy is highly problematic and unlikely in Deutsche's view.

"A levy could raise up to £5bn per year," it said. "We estimate this has a 10% earnings impact on the UK banks, with NatWest most affected."

However, there are many complications, Deutsche Bank said.

"Firstly, quantifying the reserve base at bank level is impossible. Secondly, tying a tax to liquidity would encourage banks to repay liquidity facilities and could quickly contract monetary supply.

"Thirdly, a large part of the banking system is building societies which operate with very low margins and would be disproportionately impacted.

"Lastly, the risk that it interferes with monetary transmission is high."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.